Skip to content

role of polyherbal compound in prediabetes

A clinical evaluation of a polyhebal formulation in the management of prediabetes with special reference to prameha poorvarupavastha.-A randomised double blind placebo controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/01/005471
Enrollment
100
Registered
2015-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E889- Metabolic disorder, unspecified Health Condition 2: null- Pre-Diabetes

Interventions

Intervention1: Ayurvedic Polyherbal formulation: An Ayurvedic polyherbal Formulation. 1 gm (2 capsules)BD (2 gm/day) orally with warm water. Each 500 mg capsule water extract of tinospora cordifolia +

Sponsors

RAPodar Ayu Medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Age > 18 yrs. 2)Newly diagnosed c pre-diabetes i.e. IFG 100 - 125 mg/dl & IGT 140 - 199 md/dl) 3)Able & willing to give informed consent

Exclusion criteria

Exclusion criteria: 1)Current use of oral hypoglycemic drug 2)Prior use of medication to treat diabetes Except G.D. 3)Have been diagnosed c DM by result of FPG ( > 126 mg / dl) 4)Abnormal LFT 5)Present with kidney failure 6)Received any Herbal medication for DM or Prediabetes with in 1 Mouth. 7)Pregnancy & lactation 8)Previously participated in any other clinical trial with in one month 9)HIV or AIDS pts. 10)Known allergic reaction to ingredient or PDBT. 11) Any other serious life threatning condition.

Design outcomes

Primary

MeasureTime frame
Primary End point 1)Progression of prediabetes to diabetes. 2)Reversion to normoglycemia from IGT and/or IFGTimepoint: 6 months

Secondary

MeasureTime frame
effects on lipid profile HOMA IRTimepoint: 6 months

Countries

India

Contacts

Public ContactDr K R Kohli

R.A.Podar( Ayu) Medical college

krkohli@rediffmail.com9869329777

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026